Cetuximab in Head and Neck Cancer Patients

Conditions:   Head and Neck Cancer;   Squamous Cell Carcinoma
Intervention:   Drug: Cetuximab
Sponsors:   University of Wisconsin, Madison;   National Cancer Institute (NCI);   National Institute of Dental and Craniofacial Research (NIDCR)
Not yet recruiting

https://ift.tt/2UmuFcc